These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24325745)
1. Association of surface contamination by antineoplastic drugs with different working conditions in hospital pharmacies. Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Synek S; Blaha L Arch Environ Occup Health; 2014; 69(3):148-58. PubMed ID: 24325745 [TBL] [Abstract][Full Text] [Related]
2. Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. Brouwers EE; Huitema AD; Bakker EN; Douma JW; Schimmel KJ; van Weringh G; de Wolf PJ; Schellens JH; Beijnen JH Int Arch Occup Environ Health; 2007 Aug; 80(8):689-99. PubMed ID: 17377802 [TBL] [Abstract][Full Text] [Related]
3. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs. Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy]. Leboucher G; Serratrice F; Bertholle V; Thore L; Bost M Bull Cancer; 2002 Nov; 89(11):949-55. PubMed ID: 12495882 [TBL] [Abstract][Full Text] [Related]
6. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
7. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Schierl R; Böhlandt A; Nowak D Ann Occup Hyg; 2009 Oct; 53(7):703-11. PubMed ID: 19620232 [TBL] [Abstract][Full Text] [Related]
8. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. Hedmer M; Wohlfart G J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549 [TBL] [Abstract][Full Text] [Related]
9. Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators. Kopp B; Crauste-Manciet S; Guibert A; Mourier W; Guerrault-Moro MN; Ferrari S; Jomier JY; Brossard D; Schierl R Ann Occup Hyg; 2013 Apr; 57(3):374-83. PubMed ID: 23091112 [TBL] [Abstract][Full Text] [Related]
10. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Siderov J; Kirsa S; McLauchlan R J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949 [TBL] [Abstract][Full Text] [Related]
11. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876 [TBL] [Abstract][Full Text] [Related]
12. Exposure to antineoplastic drugs in two UK hospital pharmacy units. Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878 [TBL] [Abstract][Full Text] [Related]
13. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. Hon CY; Teschke K; Chu W; Demers P; Venners S J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Hedmer M; Jönsson BA; Nygren O J Environ Monit; 2004 Dec; 6(12):979-84. PubMed ID: 15568047 [TBL] [Abstract][Full Text] [Related]
15. [Determination of airborne and surface contamination with cyclophosphamide at the Masaryk Memorial Cancer Institute, Brno, Czech Republic]. Gorná L; Odráska P; Dolezalová L; Piler P; Oravec M; Bláha L Ceska Slov Farm; 2011 Feb; 60(1):25-31. PubMed ID: 21650015 [TBL] [Abstract][Full Text] [Related]
16. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696 [TBL] [Abstract][Full Text] [Related]
17. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of surface contamination in a hospital hematology--oncology pharmacy. Touzin K; Bussières JF; Langlois E; Lefebvre M J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557 [TBL] [Abstract][Full Text] [Related]
20. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. Harrison BR; Peters BG; Bing MR Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]